Oncogenic mutation in other tumor types also correlated significantly with HIF activation, most commonly TP53, MUC16, PTEN, ARID1A, and TTN. This indicates that oncogenic mutations beyond those in the VHL gene are associated with altered HIF activation across a wide range of tumor types. Here, TP53 is linked to neoplasm.